SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-24-005906
Filing Date
2024-04-26
Accepted
2024-04-26 16:11:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20240424xdefa14a.htm DEFA14A 17627
2 GRAPHIC tmb-20240424xdefa14a_bg001.jpg GRAPHIC 167454
3 GRAPHIC tmb-20240424xdefa14a_bg002.jpg GRAPHIC 117086
  Complete submission text file 0001558370-24-005906.txt   410763
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40236 | Film No.: 24883793
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)